Bellefonte, PA, November 15, 2023 – Actuated Medical, a leading innovator in medical device technologies, proudly announces the receipt of FDA 510(k) clearance for its groundbreaking GripTract-GI™ Endoscopic Tissue Manipulator (GripTract-GI). This milestone marks a significant advancement in minimally invasive procedures, empowering healthcare professionals with a state-of-the-art tool for enhanced precision and control in complex gastrointestinal interventions.
GripTract-GI, developed and patented by Actuated Medical’s team of experts, is designed to revolutionize endoscopic tissue manipulation, offering unparalleled maneuverability and versatility. With this FDA clearance, Actuated Medical reaffirms its commitment to delivering cutting-edge solutions that elevate patient care and procedural outcomes.
“The FDA clearance for GripTract-GI is a testament to Actuated Medical’s dedication to innovation and excellence in medical device development,” said Maureen L. Mulvihill, CEO and Founder of Actuated Medical. “This milestone underscores our commitment to advancing medical procedures, providing healthcare professionals with tools that redefine the possibilities of minimally invasive interventions.”
GripTract is a single-use device that connects to the distal end of an endoscope without occupying the working channel. It assists clinicians with optical visualization, diagnosis, and endoscopic treatment. It was developed under National Institutes of Health (NIH) Small Business Innovation Research (SBIR) funding.
Actuated Medical’s relentless pursuit of excellence is reflected not only in the GripTract-GI but also in the company’s overall portfolio, which spans various medical specialties. The FDA clearance reinforces Actuated Medical’s position as a leader in medical device innovation, poised to make a lasting impact on the landscape of minimally invasive procedures.
Recent Comments